YD Bio Ltd

YD Bio Limited was originally incorporated in Delaware under the name True Velocity, Inc. on February 6, 2024. The Company was re-domesticated and registered by way of continuation as a Cayman Islands exempted company limited by shares on November 14, 2024 and changed its name to YD Bio Limited on November 18, 2024. The Company was re-domesticated solely for the purpose of the transactions contemplated by the Merger Agreement, pursuant to which the Business Combination was completed on August 28, 2025. YD Biopharma was incorporated in the Cayman Islands on March 14, 2024 in connection with the restructuring of Yong Ding Biopharm Co., Ltd., a company incorporated in the Republic of China on April 23, 2013 ( Yong Ding ), upon which YD Biopharma acquired all of the issued an outstanding equity interests of Yong Ding. Our principal executive office is located at 12F., No. 3, Xingnan St., Nangang Dist., Taipei City 115001, Taiwan, and our phone number is +(886) 2382-0330. Our agent for service in the United States is Cogency Global Inc., whose address is 122 East 42nd Street, 18th Floor, New York, NY 10168. On August 28, 2025, the Company completed its Business Combination with Breeze and YD Biopharma. As a result of the business combination, both Breeze and YD Biopharma became wholly-owned subsidiaries of the Company. As a direct consequence of the closing of the business combination, the Patent Licensing and Technology Transfer Agreement (the Agreement ), executed between EG BioMed Co., LTD. and Yong Ding Biopharm Co., Ltd ( Yong Ding ) became effective on August 28, 2025.